{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:41:15Z","timestamp":1788417675697,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1538,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1742-1241.2011.02706.x","type":"journal-article","created":{"date-parts":[[2011,6,17]],"date-time":"2011-06-17T01:05:13Z","timestamp":1308272713000},"page":"741-748","source":"Crossref","is-referenced-by-count":22,"title":["Adherence to lipid-lowering agents among 11,042 patients in clinical practice"],"prefix":"10.1155","volume":"65","author":[{"given":"M. C. S.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Y.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Griffiths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,16]]},"reference":[{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB1|cit1","volume-title":"The World Health Report 2002 - Reducing Risks, Promoting Healthy Life","author":"World Health Organization","year":"2002"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.CIR.81.5.1721","article-title":"The cholesterol facts: a summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung and Blood Institute. The Task Force on Cholesterol Issues. American Heart Association","volume":"81","author":"LaRosa","year":"1990","journal-title":"Circulation"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 50 056 participants in 14 randomized trials of statins","volume":"366","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaborators","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1185\/030079902125000787","article-title":"Treatment with atorvastatin to the National Cholesterol Educational Program goal versus \u2018usual\u2019 care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","volume":"18","author":"Athyros","year":"2002","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group","volume":"339","author":"Long-term Intervention with Pravastatin in Ischemic Heart Disease (LIPID) study group","year":"1998","journal-title":"NEJM"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"NEJM"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1185\/03007990903500565","article-title":"Centralized Pan-European survey on the under-treatment of hypercholesterolaemia (CEPHEUS): overall findings from eight countries","volume":"26","author":"Hermans","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1185\/03007990903512396","article-title":"Undertreatment of hypercholesterolemia","volume":"26","author":"Daskalopoulou","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/HJR.0b013e32832f3b56","article-title":"Assessing overall duration of cardiovascular medicines in veterans with established cardiovascular disease","volume":"17","author":"Roughead","year":"2010","journal-title":"European Journal of Cardiovascular Prevention & Rehabilitation"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1742-1241.2010.02445.x","article-title":"The economic consequences of non-adherence to lipid-lowering therapy: results from the Anglo-Scandinavian-Cardiac Outcomes Trial","volume":"64","author":"Lindgren","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB13|cit13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004371.pub3","article-title":"Interventions to improve adherence to lipid lowering medication","author":"Schedlbauer","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1742-1241.2009.02302.x","article-title":"Adherence to statin therapy: the key to survival?","volume":"64","author":"Anderson","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1517\/14656560903376186","article-title":"Non-adherence to statin therapy: a major challenge for preventive cardiology","volume":"10","author":"Bates","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB16|cit16","first-page":"895","article-title":"Factors associated with antihypertensive drug compliance in 83,884 Chinese patients: a cohort study","volume":"64","author":"Wong","year":"2009","journal-title":"JECH"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/hr.2009.229","article-title":"Adherence to combination therapy among ethnic Chinese patients: a cohort study","volume":"33","author":"Wong","year":"2010","journal-title":"Hypertens Res"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB18|cit18","unstructured":"HA and Clinical Research - Support, Output and Direction http:\/\/www.ha.org.hk\/ho\/research_ethics\/msdc_p181.pdf"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1472-6963-8-138","article-title":"Health services research in the public healthcare system in Hong Kong: an analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data","volume":"8","author":"Wong","year":"2008","journal-title":"BMC Health Services Research"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB20|cit20","unstructured":"Population by-Census, 2006, Hong Kong Special Administrative Region, China http:\/\/www.bycensus2006.gov.hk\/en\/data\/data3\/index.htm"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.0000222373.59104.3d","article-title":"Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data","volume":"47","author":"Halpern","year":"2006","journal-title":"Hypertension"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.clinthera.2009.11.030","article-title":"Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims","volume":"31","author":"McHorney","year":"2009","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB23|cit23","first-page":"450","article-title":"Medication adherence and use of generic drug therapies","volume":"15","author":"Briesacher","year":"2009","journal-title":"American Journal of Managed Care"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1185\/03007990903297741","article-title":"Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence","volume":"25","author":"Balu","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB25|cit25","first-page":"710","article-title":"Effect of medication burden on persistent use of lipid-lowering drugs among patients with hypertension","volume":"14","author":"Robertson","year":"2008","journal-title":"American Journal of Managed Care"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB26|cit26","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511811692","volume-title":"Multivariable Analysis: A Practical Guide for Clinicians","author":"Katz","year":"2006"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MJT.0b013e31816b69bc","article-title":"Does synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy?","volume":"16","author":"Agarwal","year":"2009","journal-title":"Am J Ther"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","article-title":"Adherence with statin therapy in elderly patients with and without acute coronary syndromes","volume":"288","author":"Jackevicius","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.clinthera.2007.12.022","article-title":"Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study","volume":"29","author":"Ye","year":"2007","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2125.2004.02202.x","article-title":"Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease","volume":"58","author":"Cheng","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB31|cit31","article-title":"Adherence to oral hypoglycemic agents in 26 782 Chinese patients: a cohort study","author":"Wong","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.clinthera.2009.10.004","article-title":"Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study","volume":"31","author":"Wong","year":"2009","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/0091270009346058","article-title":"Antihypertensive drug adherence among 6408 Chinese patients on angiotensin-converting enzyme inhibitors in Hong Kong: a cohort study","volume":"50","author":"Wong","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ajh.2009.95","article-title":"Factors associated with compliance, discontinuation and switching of calcium channel blockers in 20,156 Chinese patients","volume":"22","author":"Wong","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB35|cit35","first-page":"31","article-title":"Persistence with treatment for hypertension in actual practice","volume":"160","author":"Caro","year":"1999","journal-title":"CMAJ"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/hy0901.091681","article-title":"Predictors of uncontrolled hypertension in ambulatory patients","volume":"38","author":"Knight","year":"2001","journal-title":"Hypertension"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1592\/phco.20.11.941.35266","article-title":"The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs","volume":"20","author":"Billups","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1742-1241.2011.02706.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740338.2011.540568","article-title":"Statin-induced myopathy: a review and update","volume":"10","author":"Abd","year":"2011","journal-title":"Expert Opin Drug Saf"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02706.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2011.02706.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T01:07:54Z","timestamp":1643332074000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2011.02706.x"}},"subtitle":["Adherence to lipid-lowering agents"],"short-title":[],"issued":{"date-parts":[[2011,6,16]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02706.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6,16]]}}}